
Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 13, 2020, titled "Zydus Cadila receives final approval from the USFDA for Sevelamer Carbonate Tablets".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 13, 2020, titled "Zydus Cadila receives final approval from the USFDA for Sevelamer Carbonate Tablets".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences